Local Institution - 0032

Milan 20159

2 studies enrolling now · 3 studies all time

What they study most

High-grade Serous Ovarian Carcinoma (HGSOC), Muscle-Invasive Bladder Cancer, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer (NSCLC), Urinary Bladder Neoplasms, Uterine Serous Carcinoma (USC)

Studies at this site

• Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01) — Recruiting now
• A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. — Recruiting now
• A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer — Running, not enrolling